Analyst Opinion Summary: UnitedHealth Group Incorporated (UNH), Altria Group, Inc. (MO)
- Author: Zachary Reyes Apr 18, 2017,
Apr 18, 2017, 20:52
UnitedHealth (NYSE:UNH), the largest health insurer in the USA, is scheduled to announce its first quarter 2017 earnings on Tuesday, April 18. Institutions are now holders of 86.90% of the shares. UnitedHealth Group accounts for approximately 1.6% of Viking Global Investors LP's holdings, making the stock its 19th largest position. The Moving Average SMA50 is 1.41% while SMA200 is 11.04%.
A number of other hedge funds have also bought and sold shares of UNH. Bank of Hawaii acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $212,000. National Pension Service increased its stake in UnitedHealth Group by 8.7% in the third quarter. Looking at this figure it suggests that the shares of UnitedHealth Group Incorporated (UNH) may be overvalued, however, this can also depend upon the situation of the market; if the market is strong then it could suggest that UnitedHealth Group Incorporated (UNH) is a good investment, however if the market is weaker then it could suggest that the shares are undervalued. 1,606 are owned by B And T Management Dba Alpha Management. The Illinois-based Calamos Advsrs Limited Liability Company has invested 0.56% in UnitedHealth Group Inc (NYSE:UNH). Voya Investment Management Llc sold 169,233 shares as Unitedhealth Group Inc (UNH)'s stock declined 0.61%. The firm has a market capitalization of $159.02 billion, a P/E ratio of 23.06 and a beta of 0.68. The stock's 50 day moving average price is $166.65 and its 200 day moving average price is $156.50. On an adjusted basis, when taking out one-time gains and costs, earnings came to $2.37 per share of UNH stock, or 20 cents above consensus estimates. Revenue climbed 9% to $48.7 billion, which was a bit faster than the growth rate most investors were expecting. Endurant Cap Mngmt LP has invested 3.52% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). The company's revenue was up 9.0% compared to the same quarter previous year. Accordingly, the company now expects to achieve GAAP earnings of $9.10 - $9.30 and adjusted earnings of $9.65 - $9.85 a share. It is calculated by dividing the current closing price of the stock by the latest quarter's book value per share.
Let's take a look at how the stock has been performing recently. The ex-dividend date was Wednesday, March 8th.
Since January 1, 0001, it had 0 insider purchases, and 9 selling transactions for $2.68 million activity.
COPYRIGHT VIOLATION WARNING: This article was reported by BBNS and is the sole property of of BBNS. Finally, Zacks Investment Research raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $190.00 target price for the company in a research report on Tuesday, March 21st.
UnitedHealth Group Incorporated (UNH) ended its last session at $167.18 by Surging 1.35%. Leerink Swann upped their price target on UnitedHealth Group from $195.00 to $210.00 and gave the stock a "hold" rating in a report on Tuesday, February 28th. The company presently has an average rating of "Buy" and a consensus target price of $179.00.
UnitedHealth Group Incorporated (UNH) now has a consensus Price Target of $183.95. HOOPER MICHELE J had sold 15,000 shares worth $2.56 million. The stock was sold at an average price of $150.55, for a total transaction of $822,003.00. The sale was disclosed in a filing with the SEC, which is available through this link. Over the last quarter, insiders have sold 35,310 shares of company stock worth $5,855,416. The disclosure for this sale can be found here.
In related news, Director Gail R. Wilensky sold 5,460 shares of UnitedHealth Group stock in a transaction dated Thursday, November 17th.